Innocrin Pharmaceuticals is moving forward with a prostate cancer drug that it believes could better target the cancer while also causing fewer side effects compared to existing treatments. Now the company has some additional cash to try and make its case.
Humans need to communicate with each other in order to get things done – at work and at home. But so do the cells inside our bodies, which transmit messages from their outer walls to their inner nucleus. These messages prompt them to take immediate action. Now, it turns out that if cancerous cells don’t receive certain messages, the spread of cancer throughout the body can be halted. How? Israeli researchers have come up with a method of shutting off the overflow of information that creates cancerous mutations.
Medical researchers are constantly looking for ways to administer treatments to suffering patients in less painful and inconvenient ways. We recently wrote about the temporary tattoo which could provide a non-invasive alternative to diabetics’ daily blood tests. The Neulasta Delivery Kit is another such device which could improve treatment conditions — it is an on-body injector that can help ward off some of the side effects of chemotherapy by delivering pegfilgrastim to patients the day after their treatment starts.
Des scientifiques ont découvert une substance, provenant d'un arbuste africain, qui tue les cellules cancéreuses des reins. Les chercheurs de l'Institut Max-Planck de physiologie moléculaire (Dortmund, Rhénanie du nord-Westphalie) ont découvert que l'englérine A augmente fortement la concentration en calcium dans les cellules, ce qui tue les cellules cancéreuses.
Les cancers figurent parmi les principales causes de morbidité et de mortalité dans le monde; en 2012, on comptait approximativement 14 millions de nouveaux cas et 8,2 millions de décès liés à la maladie. On estime que le nombre de cas de cancer par an devrait augmenter de 14 millions en 2012 à 22 millions au cours des deux prochaines décennies. La détection et le traitement précoces des cas permettent de réduire la mortalité due au cancer.
Les ondes électromagnétiques, telles que les ondes radios ou les rayonnements émis par les téléphones portables, favoriseraient la croissance de tumeurs chez la souris, selon une étude de l'Université Jacobs de Brême.
Des chercheurs de l'Institut Fraunhofer pour la toxicologie et la médecine expérimentale (ITEM, Basse-Saxe) avaient déjà mené en 2010 une étude sur la possible influence des champs de radiofréquences UMTS [1], émis par les pylônes de téléphonie mobile et liés au développement des réseaux 3G et 4G, sur le développement des tumeurs. Cette étude avait montré qu'une exposition prolongée aux champs UMTS stimulait la croissance des cellules cancéreuses.
Throughout its history, Epizyme has always kept an eye on staying independent. When it was accumulating partnerships for its epigenetics research a few years ago, it made sure to preserve its ability to maneuver and keep some upside for its work. In a broad deal with Celgene for instance, it kept U.S. rights to a bunch of potential drugs. In a pact with Eisai, it kept an option to buy back into some of the potential profits.
Today, the Cambridge, MA-based company is doing that again. Feeling it has a drug with better potential than it originally thought, it’s cut a deal with Eisai to get back more rights than it originally bargained for.
Selon le magazine américain MIT Technology Review, on doit l'une des dix découvertes capitales de l'année au chercheur hongkongais Dennis Lo, directeur du Li Ka Shing Institute of Health Sciences et vice-doyen de la faculté de médecine de la Chinese University of Hong Kong (CUHK).
An Israeli medical device to check for the presence of cervical cancer could be an important factor in reducing the rate of death from the disease in the developing world.
Biop Medical founder and CEO Ilan Landesman believes that his examination device — the only one that provides instant readings and results on whether a woman is suffering from cervical cancer — could be a boon to women everywhere, especially in places like Africa.
Everything about China is big, including its cancer problem. In some wealthier cities, like Beijing, cancer is now believed to be the most frequent killer. Air pollution, high rates of smoking, and notorious “cancer villages” scarred by industrial pollution are increasing death rates around the country. Liver cancer in particular is four times as prevalent as it is in the West, in part because one in 14 people in China carry hepatitis B, which puts them at risk. Of all the people worldwide who die of cancer each year, some 27 percent are Chinese.
